You can't change whether a drug works in a human body — half of trials fail for efficacy, a third for safety. No amount of AI changes that.
What you can change is how fast each trial finds patients and how efficiently each approved drug reaches them. Both depend on finding the right physicians — investigators with the right patient populations, KOLs positioned to move scientific conversation, prescribers whose practices match the drug.
Spellbinder delivers that match, across clinical trials, medical affairs, and commercial launches.
Smart Targeting
We deliver the ranked list, you don't build it. For clinical teams, physicians are ranked by patient population match. For medical affairs, by peer-network position and scientific influence. For commercial, by conversion potential.
No SQL to write. No vendor data to reconcile. No "Early Adopter" taxonomy to maintain. The list is ready when your team arrives at work.
96%
Conversion Intelligence
Every interaction comes with a personalized brief. For CRCs, the eligibility questions match this physician's patient mix. For MSLs, the open scientific questions this KOL has been asking. For reps, the efficacy data this prescriber cares about, with objections anticipated.
The briefs refine themselves as you build the relationship. Every conversation gets smarter.
2.3x
We're building toward a world where no patient waits months for a treatment that could save their life. Where when a breakthrough happens anywhere in medicine, every relevant physician knows about it immediately.
A patient diagnosed with aggressive cancer won't lose precious weeks while their doctor learns about the treatment that could help them. Commercial success will happen faster, funding more R&D, creating more breakthroughs.
"Spellbinder is driving more simplicity, clarity, and direction for our sales team. It minimized the amount of time they're doing research to figure out who they need to go talk to. They can just focus on getting in front of these physicians now."
Head of Commercial Operations
Emerging Pharmaceutical Company
